Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial.
Razieh JavaherirenaniSeyede Salehe MortazaviMohammadreza ShalbafanAhmad AshouriAbbas Ramezani FaraniPublished in: BMC psychiatry (2022)
Iranian Registry of Clinical Trials, IRCT ID: IRCT20210214050353N1 , Registered on 16/10/2021.